Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Corá-Locatelli

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|October 15, 1998
Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorderG Corá-Locatelli, B D Greenberg, J Martin, et al.
The Journal of Clinical Psychiatry|March 21, 1998
Valproate monotherapy in an SRI-intolerant OCD patientG Corá-Locatelli, B D Greenberg, J D Martin, et al.
The Journal of Clinical Psychiatry|April 16, 1998
Rebound psychiatric and physical symptoms after gabapentin discontinuationG Corá-Locatelli, B D Greenberg, J D Martin, et al.
Cellular and Molecular Neurobiology|June 24, 1999
Metabolism and excretion of mood stabilizers and new anticonvulsantsT A Ketter, M A Frye, G Corá-Locatelli, et al.
Molecular Psychiatry|October 19, 1999
Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorderD Bengel, B D Greenberg, G Corá-Locatelli, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Possible gabapentin-induced thyroiditisM A Frye, D Luckenbaugh, T A Kimbrell, et al.
Neurology|January 15, 2000
Altered cortical excitability in obsessive-compulsive disorderB D Greenberg, U Ziemann, G Corá-Locatelli, et al.
Journal of Affective Disorders|July 21, 1998
Clozapine in bipolar disorder: treatment implications for other atypical antipsychoticsM A Frye, T A Ketter, L L Altshuler, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Gabapentin does not alter single-dose lithium pharmacokineticsM A Frye, T A Kimbrell, R T Dunn, et al.
Biological Psychiatry|July 1, 1999
Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depressionM A Frye, R T Dunn, K A Gary, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|October 15, 1998
Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorderG Corá-Locatelli, B D Greenberg, J Martin, et al.
The Journal of Clinical Psychiatry|March 21, 1998
Valproate monotherapy in an SRI-intolerant OCD patientG Corá-Locatelli, B D Greenberg, J D Martin, et al.
The Journal of Clinical Psychiatry|April 16, 1998
Rebound psychiatric and physical symptoms after gabapentin discontinuationG Corá-Locatelli, B D Greenberg, J D Martin, et al.
Cellular and Molecular Neurobiology|June 24, 1999
Metabolism and excretion of mood stabilizers and new anticonvulsantsT A Ketter, M A Frye, G Corá-Locatelli, et al.
Molecular Psychiatry|October 19, 1999
Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorderD Bengel, B D Greenberg, G Corá-Locatelli, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Possible gabapentin-induced thyroiditisM A Frye, D Luckenbaugh, T A Kimbrell, et al.
Neurology|January 15, 2000
Altered cortical excitability in obsessive-compulsive disorderB D Greenberg, U Ziemann, G Corá-Locatelli, et al.
Journal of Affective Disorders|July 21, 1998
Clozapine in bipolar disorder: treatment implications for other atypical antipsychoticsM A Frye, T A Ketter, L L Altshuler, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Gabapentin does not alter single-dose lithium pharmacokineticsM A Frye, T A Kimbrell, R T Dunn, et al.
Biological Psychiatry|July 1, 1999
Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depressionM A Frye, R T Dunn, K A Gary, et al.
Pageof 2